Sustained effects of once-daily memantine treatment on cognition and functional communication skills in patients with moderate to severe Alzheimer's disease: results of a 16-week open-label trial. (Q53318087)
Jump to navigation
Jump to search
scientific article published in January 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Sustained effects of once-daily memantine treatment on cognition and functional communication skills in patients with moderate to severe Alzheimer's disease: results of a 16-week open-label trial. |
scientific article published in January 2011 |
Statements
Sustained effects of once-daily memantine treatment on cognition and functional communication skills in patients with moderate to severe Alzheimer's disease: results of a 16-week open-label trial. (English)
Michael Rainer
Hans-Hermann Klünemann
Alexander Kurz
Stefanie Wolf
Kati Sternberg
Frank Tennigkeit
1 January 2011
25
3
463-475